Overall and subgroup prevalence of acne vulgaris among patients with hidradenitis suppurativa - 12/04/19
Supported in part by an education grant from AbbVie. The sponsor has had no role in the design and conduct of the study; collection, management, analysis and interpretation of data; preparation, review, or approval of the manuscript; decision to submit the manuscript for publication. |
|
Dr Garg has served as an advisor for AbbVie, Pfizer, Janssen, UCB, Asana Biosciences, and has received honoraria. Ms Wertenteil and Mr Strunk have no conflicts of interest to disclose. |
|
This investigation was approved by the Feinstein Institute for Medical Research institutional review board at Northwell Health. |
Vol 80 - N° 5
P. e131-e132 - mai 2019 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?